We're working on adding all of our packages. Stay tuned or get in touch if you don't see what you're looking for!

Target Identification Data Package

This package has 11 modules. The Drug-Protein Relationships and Drug Targets Module has 4 tables. Preview the first five rows of each table or Explore the schema

Drug-Protein Relationships and Drug Targets Module

4 Tables

Describes the relationship between drugs and targets, enzymes, carriers, or transporters. Annotation includes the pharmacological action, and the type of interaction (antagonist, agonist, substrate, inhibitor, or inducer).

Bio-Entities

Describes proteins or other biological entities that interact with a drug (as drug targets, metabolizing enzymes, or drug carriers/transporters).

biodb_id
name
kind
organism
BE0000001
Peptidoglycan synthase FtsI
protein
Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
BE0000002
Histidine decarboxylase
protein
Humans
BE0000003
Glutaminase liver isoform, mitochondrial
protein
Humans
BE0000004
Coagulation factor XIII A chain
protein
Humans
BE0000005
Nitric oxide synthase, inducible
protein
Humans
Want all 5,997 rows? Let's connect you to sales.

Bio-Entity Components

A list of specific components of each bio-entity.

biodb_id
component_type
component_id
BE0000001
Polypeptide
P45059
BE0000002
Polypeptide
P19113
BE0000003
Polypeptide
Q9UI32
BE0000004
Polypeptide
P00488
BE0000005
Polypeptide
P35228
Want all 6,545 rows? Let's connect you to sales.

Bonds

Describes the binding relationship between drugs and targets/enzymes/carriers/transporters.

id
type
drug_id
biodb_id
pdb_id
position
pharmacological_action
antagonist
agonist
substrate
inhibitor
inducer
other_action
inducer_strength
inhibitor_strength
induction_clinically_sig
inhibition_clinically_sig
1
TargetBond
1
BE0000048
1
yes
0
0
0
1
0
unknown
0
0
2
TargetBond
2
BE0000767
1
yes
0
0
0
0
0
binder
0
0
3
TargetBond
4
BE0000658
1
yes
0
0
0
0
0
binder
0
0
4
TargetBond
5
BE0000704
1
yes
0
0
0
1
0
antibody
unknown
0
0
5
TargetBond
6
BE0000048
1
yes
0
0
0
1
0
unknown
0
0
Want all 29,742 rows? Let's connect you to sales.

Polypeptides

A description of identified polypeptide targets, enzymes, carriers, or transporters.

uniprot_id
name
uniprot_name
gene_name
organism_id
molecular_weight
theoretical_pi
general_function
specific_function
signal_regions
transmembrane_regions
pdb_ids
genbank_gene_id
genbank_protein_id
genecard_id
locus
genatlas_id
hgnc_id
meta_cyc_id
ncbi_sequence_ids
tissue_specificity
cofactor
subunit
cellular_location
amino_acid_sequence
gene_sequence
A0A023W3H0
Class D OXA-48 carbapenemase
A0A023W3H0_KLEPN
OXA-48
144
16920.07
Penicillin binding
>lcl|BSEQ0022471|Class D OXA-48 carbapenemase VVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDY GNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYI IRAKTGYSTRIEPKIGWWVGWVELD
A0A024R8I1
Voltage-dependent N-type calcium channel subunit alpha
A0A024R8I1_HUMAN
CACNA1B
154
111676.12
Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1B gives rise to N-type calcium currents.
Voltage-gated calcium channel activity
99-116 136-156 223-245 333-355 484-504 510-527 548-566 609-631 687-709
Membrane
>lcl|BSEQ0052085|Voltage-dependent N-type calcium channel subunit alpha MVRFGDELGGRYGGPGGGERARGGGAGGAGGPGPGGLQPGQRVLYKQSIAQRARTMALYN PIPVKQNCFTVNRSLFVFSEDNVVRKYAKRITEWPPFEYMILATIIANCIVLALEQHLPD GDKTPMSERLDDTEPYFIGIFCFEAGIKIIALGFVFHKGSYLRNGWKVMDFVVVLTGILA TAGTDFDLRTLRAVRVLRPLKLVSGIPSLQVVLKSIMKAMVPLLQIGLLLFFAILMFAII GLEFYMGKFHKACFPNSTDAEPVGDFPCGKEAPARLCEGDTECREYWPGPNFGITNFDNI LFAILTVFQCITMEGWTDILYNTNDAAGNTWNWLYFIPLIIIGSFFMLNLVLGVLSGEFA KERERVENRRAFLKLRRQQQIERELNGYLEWIFKAEEVMLAEEDRNAEEKSPLDVLKRAA TKKSRNDLIHAEEGEDRFADLCAVGSPFARASLKSGKTESSSYFRRKEKMFRFFIRRMVK AQSFYWVVLCVVALNTLCVAMVHYNQPRRLTTTLYFAEFVFLGLFLTEMSLKMYGLGPRS YFRSSFNCFDFGVIVGSVFEVVWAAIKPGSSFGISVLRALRLLRIFKVTKYWSSLRNLVV SLLNSMKSIISLLFLLFLFIVVFALLGMQLFGGQFNFQDETPTTNFDTFPAAILTVFQIL TGEDWNAVMYHGIESQGGVSKGMFSSFYFIVLTLFGNYTLLNVFLAIAVDNLANAQELTK DEEEMEEAANQKLALQKAKEVAEVSPMSAANISIAARQQNSAKARSVWEQRASQLRLQNL RASCEALYSEMDPEERLRFATTRHLRPDMKTHLDRPLVVELGRDGARGPVGGKARPEAAE APEGVDPPRRHHRHRDKDKTPAAGDQDRAEAPKAESGEPGAREERPRPHRSHSKEAAGPP EARSERGRGPGPEGGRRHHRRGSPEEAAEREPRRHRAHRHQDPSKESPRQGRAARAAPRR PPSGAPGGGERGGAGAAAPGPAQGAACSRGCGEGDHGEGGHGEGG
A0A045ISQ8
Cytochrome D Ubiquinol oxidase subunit II
A0A045ISQ8_MYCTX
cydB
13
37626.835
Oxidoreductase activity
6-24 87-107 119-142 162-188 200-221 227-247 254-275 303-326
>lcl|BSEQ0052081|Cytochrome D Ubiquinol oxidase subunit II MVLQELWFGVIAALFLGFFILEGFDFGVGMLMAPFAHVGMGDPETHRRTALNTIGPVWDG NEVWLITAGAAIFAAFPGWYATVFSALYLPLLAILFGMILRAVAIEWRGKIDDPKWRTGA DFGIAAGSWLPALLWGVAFAILVRGLPVDANGHVALSIPDVLNAYTLLGGLATAGLFSLY GAVFIALKTSGPIRDDAYRFAVWLSLPVAGLVAGFGLWTQLAYGKDWTWLVLAVAGCAQA AATVLVWRRVSDGWAFMCTLIVVAAVVVLLFGALYPNLVPSTLNPQWSLTIHNASSTPYT LKIMTWVTAFFAPLTVAYQTWTYWVFRQRISAERIPPPTGLARRAP
A0A045KKX4
Cytochrome D ubiquinol oxidase subunit I
A0A045KKX4_MYCTX
cydA
13
53826.08
Electron transfer activity
20-41 53-71 91-115 127-150 187-208 220-242 339-361 373-394 429-451
Cell inner membrane
>lcl|BSEQ0052080|Cytochrome D ubiquinol oxidase subunit I MNVVDISRWQFGITTVYHFIFVPLTIGLAPLIAVMQTLWVVTDNPAWYRLTKFFGKLFLI NFAIGVATGIVQEFQFGMNWSEYSRFVGDVFGAPLAMEGLAAFFFESTFIGLWIFGWNRL PRLVHLACIWIVAIAVNVSAFFIIAANSFMQHPVGAHYNPTTGRAELSSIVVLLTNNTAQ AAFTHTVSGALLTAGTFVAAVSAWWLVRSSTTHADSDTQAMYRPATILGCWVALAATAGL LFTGDHQGKLMFQQQPMKMASAESLCDTQTDPNFSVLTVGRQNNCDSLTRVIEVPYVLPF LAEGRISGVTLQGIRDLQQEYQQRFGPNDYRPNLFVTYWSFRMMIGLMAIPVLFALIALW LTRGGQIPNQRWFSWLALLTMPAPFLANSAGWVFTEMGRQPWVVVPNPTGDQLVRLTVKA GVSDHSATVVATSLLMFTLVYAVLAVIWCWLLKRYIVEGPLEHDAEPAAHGAPRDDEVAP LSFAY
A0A059JJ46
ABC multidrug transporter MDR2
MDR2_TRIIM
MDR2
1913
145278.17
Pleiotropic ABC efflux transporter that may be involved in the modulation susceptibility to a wide range of unrelated cytotoxic compounds, including terbinafine, 4-nitroquinoline N-oxide, and ethidium bromide (PubMed:16849730). May play a role in pathogenicity (PubMed:19141731).
Atp binding
93-113 147-167 219-239 242-262 325-345 358-378 762-782 810-830 884-904 910-930 995-1015 1025-1045
Cell membrane
>lcl|BSEQ0052180|ABC multidrug transporter MDR2 MVEVSEKPNTQDDGVSKQENRNPASSSSSTSDKEKVAKKGNSDATKSSTPEDLDAQLAHL PEHEREILKQQLFIPDAKATYGTLFRYATRNDMIFLAIVSLASIAAGAALPLFTVLFGSL AGTFRDIALHRITYDEFNSILTRNSLYFVYLGIAQFILLYVSTVGFIYVGEHITQKIRAK YLHAILRQNIGFFDKLGAGEVTTRITADTNLIQDGISEKVGLTLTALSTFFSAFIIGYVR YWKLALICSSTIVAMILVMGGISRFVVKSGRMTLVSYGEGGTVAEEVISSIRNATAFGTQ EKLARQYEVHLKEARKWGRRLQMMLGIMFGSMMAIMYSNYGLGFWMGSRFLVGGETDLSA IVNILLAIVIGSFSIGNVAPNTQAFASAISAGAKIFSTIDRVSAIDPGSDEGDTIENVEG TIEFRGIKHIYPSRPEVVVMEDINLVVPKGKTTALVGPSGSGKSTVVGLLERFYNPVSGS VLLDGRDIKTLNLRWLRQQISLVSQEPTLFGTTIFENIRLGLIGSPMENESEEQIKERIV SAAKEANAHDFIMGLPDGYATDVGQRGFLLSGGQKQRIAIARAIVSDPKILLLDEATSAL DTKSEGVVQAALDAASRGRTTIVIAHRLSTIKSADNIVVIVGGRIAEQGTHDELVDKKGT YLQLVEAQKINEERGEESEDEAVLEKEKEISRQISVPAKSVNSGKYPDEDVEANLGRIDT KKSLSSVILSQKRSQEKETEYSLGTLIRFIAGFNKPERLIMLCGFFFAVLSGAGQPVQSV FFAKGITTLSLPPSLYGKLREDANFWSLMFLMLGLVQLVTQSAQGVIFAICSESLIYRAR SKSFRAMLRQDIAFFDLPENSTGALTSFLSTETKHLSGVSGATLGTILMVSTTLIVALTV ALAFGWKLALVCISTVPVLLLCGFYRFWILAQFQTRAKKAYESSASYACEATSSIRTVAS LTREQGVMEIYEGQLNDQAKKSLRSVAKSSLLYAASQSFSFFCLALGFWYGGGLLGKGEY NAFQFFLCISCVIFGSQSAGIVFSFSPDMGKAKSAAADFKRLFDRVPTIDIESPDGEKLE TVEGTIEFRDVHFRYPTRPEQPVLRGLNLTVKPGQYIALVGPSGCGKSTTIALVERFYDT LSGGVYIDGKDISRLNVNSYRSHLALVSQEPTLYQGTIRDNVLLGVDRDDVPDEQVFAAC KAANIYDFIMSLPDGFGTVVGSKGSMLSGGQKQRIAIARALIRDPKVLLLDEATSALDSE SEKVVQAALDAAAKGRTTIAVAHRLSTIQKADIIYVFDQGRIVESGTHHELLQNKGRYYE LVHMQSLEKTQ
Want all 5,941 rows? Let's connect you to sales.

Showing 4 of 4 tables